Kutatási jelek – Signal Engine

• First Patient Dosed in VIR-5500 T-Cell Engager Trial in Metastatic Prostate Cancer — Prostate cancer
• Subcutaneous tarlatamab exhibits low toxicity rates in phase 1b trial — SCLC
• Phase 2 study highlights flexible dosing options for tarlatamab in relapsed SCLC — SCLC
• Frontiers | Lamins’ role in osteosarcoma — Osteosarcoma
• Cancer drug response and resistance: molecular mechanisms and combating strategies — NSCLC
• Photodynamic therapy mediated by a selective nanoemulsion for breast cancer treatment: in vitro and in vivo evaluation — Breast cancer
• History of the early development of aromatase inhibitors for treatment of breast cancer — Breast cancer
• Real-world safety profile of mitotane in adrenocortical carcinoma: a retrospective cross‑sectional study integrating pharmacovigilance and interpretable machine learning — Adrenocortical carcinoma
• A retrospective cohort study of surgery for adrenocortical carcinoma in a tertiary endocrine surgery unit — Adrenocortical carcinoma
• Integration of nanotechnology in triple negative breast cancer research: a bibliometric and emerging trends analysis — Breast cancer
• Challenges and advances in drug resistance and tolerance in cancer — NSCLC
• Deep learning-based PET/CT mixture-of-experts model for relapse risk stratification in relapsed/refractory classical Hodgkin lymphoma: a multicenter study — Hodgkin lymphoma
• Harnessing lipid metabolism to surmount treatment resistance in aggressive non‑Hodgkin lymphoma: from regulatory networks to novel therapeutic opportunities — Diffuse large B-cell lymphoma
• Targeting cutaneous T‑cell lymphoma in non‑Hodgkin lymphoma: what's new for investigational agents — Hodgkin lymphoma
• Combination therapy with doxorubicin and Berberis asiatica induces mitochondrial-mediated apoptosis and inhibits the PI3K/Akt pathway in non‑Hodgkin lymphoma — Colorectal cancer
• Long‑term results of the HD0607 trial on interim PET‑adapted treatment of advanced‑stage Hodgkin lymphoma beyond 10 years of follow‑up — Hodgkin lymphoma
• Late cardiopulmonary morbidity in patients with Hodgkin lymphoma: a retrospective nationwide registry study — Hodgkin lymphoma
• Refining risk stratification for mantle cell lymphoma: integrating novel combination treatments and personalized approaches. — Mantle cell lymphoma
• Treatment evolution and survival impact of consolidation therapies in mantle cell lymphoma: insights from an Asia-Pacific real-world registry — Mantle cell lymphoma
• Mantle cell lymphoma artificial intelligence prognostic index using hematoxylin and eosin histology — Mantle cell lymphoma